Tyton Biosciences
Danville, US
Founders & leadership
PM
Peter MajeranowskiExecutive Officer, Director
GC
Greg CurtisDirector
ES
Edward Scott, Jr.Director
LH
Luke HenningExecutive Officer
Reported raises · per SEC filings
Form D private placements$25MraisedMar 2023 · 8 investors · Manufacturing
Rule 506(b)$2MraisedDec 2021 · 1 investors · Manufacturing
Rule 506(b)$5.5MraisedSep 2021 · 27 investors · Other
Rule 506(b)$4.2MraisedAug 2019 · 11 investors · Other
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.